WEDD



Trademark Coverage

No Class Specified

product development, namely, technology elements used for developing a technology platform for drug delivery systems; development of new technology for others in the field of wearable electronic transdermal technology platforms for use in product development for drug delivery systems

Owners

TEIKOKU PHARMA USA, INC.

Business in SAN JOSE, CA

Owns 22 trademarks

TRAVANTI PHARMA INC.

Business in MENDOTA HEIGHTS, MN

Owns 8 trademarks

Timeline
  • Nov 20
    2013
    Notice Of Acceptance Of SEC 8 & 9 E Mailed
  • Nov 20
    2013
    Registered And Renewed (First Renewal 10 Yrs)
  • Nov 20
    2013
    Registered SEC 8 (10 Yr) ACCEPTED/SEC 9 Granted
  • Nov 05
    2013
    Registered Combined Section 8 (10 Yr) & SEC 9 Filed
  • Nov 20
    2013
    Case Assigned To Post Registration Paralegal
  • Nov 05
    2013
    TEAS Section 8 & 9 Received
  • Aug 01
    2012
    Automatic Update Of Assignment Of Ownership
  • Aug 24
    2009
    Registered SEC 8 (6 Yr) Accepted & SEC 15 ACK
  • Aug 06
    2009
    Assigned To Paralegal
  • Jul 24
    2009
    Registered SEC 8 (6 Yr) & SEC 15 Filed
  • Jul 24
    2009
    Paper Received
  • Sep 13
    2006
    Automatic Update Of Assignment Of Ownership
  • Nov 18
    2003
    Registered Principal Register
  • Sep 22
    2003
    Allowed Principal Register SOU Accepted
  • Sep 22
    2003
    Assigned To Examiner
  • Sep 17
    2003
    Case File In TICRS
  • Aug 01
    2003
    Statement Of Use Processing Complete
  • Jun 27
    2003
    Use Amendment Filed
  • Jun 27
    2003
    Paper Received
  • Jan 21
    2003
    NOA Mailed SOU Required From Applicant
  • Oct 29
    2002
    Published For Opposition
  • Oct 09
    2002
    Notice Of Publication
  • Jun 14
    2002
    Approved For PUB Principal Register
  • May 20
    2002
    Correspondence Received In Law Office
  • May 20
    2002
    Paper Received
  • Apr 04
    2002
    Non Final Action Mailed
  • Mar 28
    2002
    Assigned To Examiner